SciClone Pharmaceuticals, Inc.'s SCV-07 Inhibits Melanoma Tumor Growth in Animal Model Study

SAN MATEO, CA--(MARKET WIRE)--Jun 4, 2007 -- SciClone Pharmaceuticals, Inc. (NasdaqGM:SCLN - News) today reported data showing that SCV-07 inhibits the growth of melanoma tumors in an animal model study. These data were the subject of an abstract accepted for the Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois.

Back to news